Amgen Profile

USD 0.16  0.0941%
168.79Last Month High 175.42 
169.49Trading Day  High 170.76 

Sale by Brian McNamee of 500 shares of Amgen

Amgen Inc insider trading alert for sale of common stock by Brian McNamee, SVP Human Resources, on November 22, 2017. This event was filed by Amgen Inc with SEC on 2012-07-31. Statement of changes in beneficial ownership - SEC Form 4. Brian McNamee is currently serves as executive vice president - full potential initiatives of Amgen Inc [view details]   

Amgen Summary

Amgen Inc (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 17,900 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mega-Cap' category with current market capitalization of 123.29 B. Amgen Inc conducts business under Healthcare sector and is part of Pharmaceuticals And Biosciences industry. This company has 725.91 M outstanding shares of which 7.81 M shares are presently shorted by private and institutional investors with about 2.81 trading days to cover. AMGEN currently holds about 39.23 B in cash with 10.47 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 53.76.
Check Amgen Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected Amgen Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Amgen Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
< 39% 
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameAmgen Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock Stocks Directory
RegionNorth America
Business AddressOne Amgen Center Drive, Thousand Oaks, CA 91320-1799, United States
Foreign Associates
CIK Number00318154.0
IndustryPharmaceuticals And Biosciences
Contact Number805 447 1010
CurrencyUSD - US Dollar


Amgen Analyst Recommendations
Target PriceAdvice# of Analysts
Amgen Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Amgen Analyst Advice  

Amgen Dividends

Upcoming distributions to stockholders


Amgen Earnings Estimates
EPSEstimate Date
Quarterly Estimate2.99April 27, 2017
Amgen Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate